Opioid receptors: distinct roles in mood disorders

[1]  T. Vanderah,et al.  The delta opioid receptor , 2013 .

[2]  I. Sora,et al.  Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. , 2013, The international journal of neuropsychopharmacology.

[3]  B. Kieffer,et al.  Ligand‐directed signalling within the opioid receptor family , 2012, British journal of pharmacology.

[4]  R. Maldonado,et al.  Influence of δ-Opioid Receptors in the Behavioral Effects of Nicotine , 2012, Neuropsychopharmacology.

[5]  B. Kieffer,et al.  The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice. , 2012, European journal of pharmacology.

[6]  Shanna L Resendez,et al.  κ-Opioid Receptors within the Nucleus Accumbens Shell Mediate Pair Bond Maintenance , 2012, The Journal of Neuroscience.

[7]  Aashish Manglik,et al.  Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.

[8]  K. Lutfy,et al.  The role of mu opioid receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronide. , 2012, European journal of pharmacology.

[9]  N. Eisenberger.  The pain of social disconnection: examining the shared neural underpinnings of physical and social pain , 2012, Nature Reviews Neuroscience.

[10]  Andreas Meyer-Lindenberg,et al.  Neural mechanisms of social risk for psychiatric disorders , 2012, Nature Neuroscience.

[11]  J. Pintar,et al.  Loss of the mu opioid receptor on different genetic backgrounds leads to increased bromodeoxyuridine labeling in the dentate gyrus only after repeated injection , 2012, Neuroscience.

[12]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[13]  R. Stevens,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[14]  D. David,et al.  Functional Status of Somatodendritic Serotonin 1A Autoreceptor after Long-Term Treatment with Fluoxetine in a Mouse Model of Anxiety/Depression Based on Repeated Corticosterone Administration , 2012, Molecular Pharmacology.

[15]  A. Der-Avakian,et al.  The neurobiology of anhedonia and other reward-related deficits , 2012, Trends in Neurosciences.

[16]  I. Tkáč,et al.  Postnatal morphine administration alters hippocampal development in rats , 2012, Journal of neuroscience research.

[17]  A. Kruse,et al.  Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.

[18]  C. Nemeroff,et al.  Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal , 2011, Neuropsychopharmacology.

[19]  R. Bodnar.  Endogenous opiates and behavior: 2010 , 2011, Peptides.

[20]  B. Kieffer,et al.  Sequential and opposing alterations of 5-HT1A receptor function during withdrawal from chronic morphine , 2011, European Neuropsychopharmacology.

[21]  H. Tejeda,et al.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders , 2011, Cellular and Molecular Life Sciences.

[22]  K. Wada,et al.  The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions , 2011, Behavioural Brain Research.

[23]  I. Sora,et al.  Decreased response to social defeat stress in μ-opioid-receptor knockout mice , 2011, Pharmacology Biochemistry and Behavior.

[24]  K. Befort,et al.  The delta opioid receptor: an evolving target for the treatment of brain disorders. , 2011, Trends in pharmacological sciences.

[25]  R. Lefkowitz,et al.  Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling. , 2011, Trends in biochemical sciences.

[26]  Garet P Lahvis,et al.  Social influences on morphine-conditioned place preference in adolescent BALB/cJ and C57BL/6J mice , 2011, Psychopharmacology.

[27]  Julia C. Lemos,et al.  Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and Addiction , 2011, Neuron.

[28]  Jason S. Snyder,et al.  Adult hippocampal neurogenesis buffers stress responses and depressive behavior , 2011, Nature.

[29]  R. Hen,et al.  Experience Dictates Stem Cell Fate in the Adult Hippocampus , 2011, Neuron.

[30]  C. Zarate,et al.  Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments , 2011, Depression and anxiety.

[31]  R. Maldonado,et al.  Deletion of the δ Opioid Receptor Gene Impairs Place Conditioning But Preserves Morphine Reinforcement , 2011, Biological Psychiatry.

[32]  B. Klausz,et al.  Changes in adaptability following perinatal morphine exposure in juvenile and adult rats. , 2011, European journal of pharmacology.

[33]  A. Siracusano,et al.  Social hedonic capacity is associated with the A118G polymorphism of the mu-opioid receptor gene (OPRM1) in adult healthy volunteers and psychiatric patients , 2011, Social neuroscience.

[34]  E. Costello,et al.  Child μ-Opioid Receptor Gene Variant Influences Parent–Child Relations , 2011, Neuropsychopharmacology.

[35]  Qiang Chen,et al.  The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice , 2011, Neuroscience Letters.

[36]  B. Kieffer,et al.  Impaired Emotional-Like Behavior and Serotonergic Function During Protracted Abstinence from Chronic Morphine , 2011, Biological Psychiatry.

[37]  E. Nestler,et al.  Linking molecules to mood: new insight into the biology of depression. , 2010, The American journal of psychiatry.

[38]  L. Vanderschuren,et al.  The pleasures of play: pharmacological insights into social reward mechanisms. , 2010, Trends in pharmacological sciences.

[39]  E. Susser,et al.  Early Life Programming and Neurodevelopmental Disorders , 2010, Biological Psychiatry.

[40]  Robert A Koeppe,et al.  Dysregulation of regional endogenous opioid function in borderline personality disorder. , 2010, The American journal of psychiatry.

[41]  M. Messaoudi,et al.  Human opiorphin is a naturally occurring antidepressant acting selectively on enkephalin-dependent delta-opioid pathways. , 2010, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[42]  S. Mague,et al.  OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models. , 2010, Drug and alcohol dependence.

[43]  E. Castrén,et al.  The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity , 2010, Developmental neurobiology.

[44]  G. Koob,et al.  The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse , 2010, Psychopharmacology.

[45]  Allison T. Knoll,et al.  Dynorphin, stress, and depression , 2010, Brain Research.

[46]  M. Bruchas,et al.  The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors , 2010, Brain Research.

[47]  R. Přikryl,et al.  A118G Polymorphism of OPRM1 Gene is Associated with Schizophrenia , 2010, Journal of Molecular Neuroscience.

[48]  R. Palmiter,et al.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking , 2009, Proceedings of the National Academy of Sciences.

[49]  K. Befort,et al.  Reward processing by the opioid system in the brain. , 2009, Physiological reviews.

[50]  R. Lanius,et al.  The role of β-endorphin in the pathophysiology of major depression , 2009, Neuropeptides.

[51]  J. Micó,et al.  Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression. , 2009, The international journal of neuropsychopharmacology.

[52]  Baldwin M. Way,et al.  Variation in the μ-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection , 2009, Proceedings of the National Academy of Sciences.

[53]  J. Micó,et al.  Opiates as antidepressants. , 2009, Current pharmaceutical design.

[54]  V. Chefer,et al.  Augmentation of Morphine-Induced Sensitization but Reduction in Morphine Tolerance and Reward in Delta-Opioid Receptor Knockout Mice , 2009, Neuropsychopharmacology.

[55]  M. Olmstead,et al.  Mu and Delta Opioid Receptors Oppositely Regulate Motor Impulsivity in the Signaled Nose Poke Task , 2009, PloS one.

[56]  P. Wellman,et al.  Different affective response to opioid withdrawal in adolescent and adult mice. , 2009, Life sciences.

[57]  V. Chefer,et al.  Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. , 2008, CNS & neurological disorders drug targets.

[58]  L. Granero,et al.  Shell/core differences in mu- and delta-opioid receptor modulation of dopamine efflux in nucleus accumbens , 2008, Neuropharmacology.

[59]  Peter L Tenore,et al.  Psychotherapeutic Benefits of Opioid Agonist Therapy , 2008, Journal of addictive diseases.

[60]  B. Kieffer,et al.  Brain Regional Fos Expression Elicited by the Activation of μ- but not δ-Opioid Receptors of the Ventral Tegmental Area: Evidence for an Implication of the Ventral Thalamus in Opiate Reward , 2008, Neuropsychopharmacology.

[61]  J. Kamei,et al.  Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model , 2008, Brain Research.

[62]  David Goldman,et al.  Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates , 2008, Proceedings of the National Academy of Sciences.

[63]  B. Roques,et al.  Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours , 2008, Psychopharmacology.

[64]  S. Salvadori,et al.  Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist , 2008, Peptides.

[65]  M. Meaney,et al.  Maternal separation leads to persistent reductions in pain sensitivity in female rats. , 2007, The journal of pain : official journal of the American Pain Society.

[66]  Garet P Lahvis,et al.  Social reward among juvenile mice , 2007, Genes, brain, and behavior.

[67]  S. Watson,et al.  Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. , 2007, European journal of pharmacology.

[68]  R. Gereau,et al.  Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward , 2007, Proceedings of the National Academy of Sciences.

[69]  Dan J Stein,et al.  Opioids: From Physical Pain to the Pain of Social Isolation , 2007, CNS Spectrums.

[70]  A. Lichtman,et al.  NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action. , 2007, European journal of pharmacology.

[71]  R. Hen,et al.  Neurodevelopmental origins of depressive disorders. , 2007, Current opinion in pharmacology.

[72]  G. Aston-Jones,et al.  Activation in extended amygdala corresponds to altered hedonic processing during protracted morphine withdrawal , 2007, Behavioural Brain Research.

[73]  I. Sora,et al.  Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons , 2007, Neuroscience.

[74]  Robert A Koeppe,et al.  Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women. , 2006, Archives of general psychiatry.

[75]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[76]  E. Nestler,et al.  The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.

[77]  Shuang Li,et al.  Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System , 2006, Neuropsychopharmacology.

[78]  S. Watson,et al.  Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. , 2006, European journal of pharmacology.

[79]  S. Watson,et al.  Endogenous opioids upregulate brain‐derived neurotrophic factor mRNA through δ‐ and µ‐opioid receptors independent of antidepressant‐like effects , 2006 .

[80]  B. Sharp.  Multiple opioid receptors on immune cells modulate intracellular signaling , 2006, Brain, Behavior, and Immunity.

[81]  S. Watson,et al.  Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats , 2006, Brain Research.

[82]  B. Roques,et al.  Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment , 2005, Neuroscience.

[83]  B. Roques,et al.  Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors , 2005, Neuroscience.

[84]  J. Zubieta,et al.  Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[85]  E. Jutkiewicz,et al.  Differential Behavioral Tolerance to the δ-Opioid Agonist SNC80 ([(+)-4-[(αR)-α-[(2S,5R)-2,5-Dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley Rats , 2005, Journal of Pharmacology and Experimental Therapeutics.

[86]  James L. Howard,et al.  Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats , 2005, Psychopharmacology.

[87]  E. Jutkiewicz,et al.  Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats , 2005, Psychopharmacology.

[88]  M. Collu,et al.  Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice , 2005, Synapse.

[89]  E. Nunes,et al.  Treatment of depression in patients with opiate dependence , 2004, Biological Psychiatry.

[90]  R. Kessler.  The epidemiology of dual diagnosis , 2004, Biological Psychiatry.

[91]  H. Loh,et al.  Altered emotional behaviors and the expression of 5‐HT1A and M1 muscarinic receptors in μ‐opioid receptor knockout mice , 2004, Synapse.

[92]  A. Cowan,et al.  Buprenorphine: a unique drug with complex pharmacology. , 2004, Current neuropharmacology.

[93]  Masaaki Iwata,et al.  Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant‐like effects , 2004, Journal of neurochemistry.

[94]  P. Escribá,et al.  Increased mRNA Expression of α2A-Adrenoceptors, Serotonin Receptors and μ-Opioid Receptors in the Brains of Suicide Victims , 2004, Neuropsychopharmacology.

[95]  G. Gerra,et al.  Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. , 2004, Drug and alcohol dependence.

[96]  B. Kieffer,et al.  Deficit in Attachment Behavior in Mice Lacking the µ-Opioid Receptor Gene , 2004, Science.

[97]  K. Befort,et al.  Mu opioid receptor: a gateway to drug addiction , 2004, Current Opinion in Neurobiology.

[98]  E. Jutkiewicz,et al.  δ-Opioid Agonists: Differential Efficacy and Potency of SNC80, Its 3-OH (SNC86) and 3-Desoxy (SNC162) Derivatives in Sprague-Dawley Rats , 2004, Journal of Pharmacology and Experimental Therapeutics.

[99]  S. Watson,et al.  The δ-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats , 2004, Neuropsychopharmacology.

[100]  R. Koeppe,et al.  Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. , 2003, Archives of general psychiatry.

[101]  E. Jutkiewicz,et al.  Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats , 2003, Behavioural pharmacology.

[102]  Jaak Panksepp,et al.  Feeling the Pain of Social Loss , 2003, Science.

[103]  Philip S. Portoghese,et al.  Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.

[104]  P. Eriksson,et al.  Mu‐ and delta‐opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors , 2003, The European journal of neuroscience.

[105]  Eric J. Nestler,et al.  Inhibition of cAMP Response Element-Binding Protein or Dynorphin in the Nucleus Accumbens Produces an Antidepressant-Like Effect , 2002, The Journal of Neuroscience.

[106]  T. Robinson,et al.  Widespread but regionally specific effects of experimenter‐ versus self‐administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats , 2002, Synapse.

[107]  J. Micó,et al.  Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. , 2002, Life sciences.

[108]  R. Tao,et al.  GABAergic and Glutamatergic Afferents in the Dorsal Raphe Nucleus Mediate Morphine-Induced Increases in Serotonin Efflux in the Rat Central Nervous System , 2002, Journal of Pharmacology and Experimental Therapeutics.

[109]  R. Tao,et al.  Opioid Receptor Subtypes Differentially Modulate Serotonin Efflux in the Rat Central Nervous System , 2002, Journal of Pharmacology and Experimental Therapeutics.

[110]  E. Jutkiewicz,et al.  Convulsant activity of a non-peptidic δ-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats , 2002, Psychopharmacology.

[111]  E. Jutkiewicz,et al.  Nonpeptidic δ-opioid Receptor Agonists Reduce Immobility in the Forced Swim Assay in Rats , 2002, Neuropsychopharmacology.

[112]  C. Gaveriaux-Ruff,et al.  Opioid receptor genes inactivated in mice: the highlights , 2002, Neuropeptides.

[113]  Jamie Fong,et al.  Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization , 2002, Cell.

[114]  V. Pickel,et al.  Major coexpression of κ‐opioid receptors and the dopamine transporter in nucleus accumbens axonal profiles , 2001, Synapse.

[115]  N. Nishiyama,et al.  Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test , 2001, Psychopharmacology.

[116]  G. Koob,et al.  Increased Ethanol Self‐Administration in δ‐Opioid Receptor Knockout Mice , 2001 .

[117]  M. Kalinichev,et al.  Early neonatal experience of Long-Evans rats results in long-lasting changes in morphine tolerance and dependence , 2001, Psychopharmacology.

[118]  M. Kalinichev,et al.  Repeated neonatal maternal separation alters morphine-induced antinociception in male rats , 2001, Brain Research Bulletin.

[119]  P. Song,et al.  The involvement of glial cells in the development of morphine tolerance , 2001, Neuroscience Research.

[120]  G. Aston-Jones,et al.  Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion , 2000, Nature.

[121]  G. Aghajanian,et al.  Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway , 1999, Neuroscience.

[122]  R. Niesink,et al.  Social behavior of juvenile rats after in utero exposure to morphine: dose–time–effect relationship , 1999, Neuropharmacology.

[123]  W. Coryell,et al.  Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. , 1999, The American journal of psychiatry.

[124]  Ian Kitchen,et al.  Morphine treatment during juvenile isolation increases social activity and opioid peptides release in the adult rat , 1999, Brain Research.

[125]  K. Grasing,et al.  Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal , 1998, Neuropharmacology.

[126]  B. Roques,et al.  Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. , 1998, European journal of pharmacology.

[127]  Jerry M. Lewis,et al.  For better or worse: interpersonal relationships and individual outcome. , 1998, The American journal of psychiatry.

[128]  G. Koob,et al.  Neurobiological Similarities in Depression and Drug Dependence: A Self-Medication Hypothesis , 1998, Neuropsychopharmacology.

[129]  Shakti Sharma,et al.  Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. , 1997, Science.

[130]  B. Roques,et al.  Social interaction increases the extracellular levels of [Met]enkephalin in the nucleus accumbens of control but not of chronic mild stressed rats. , 1997, Neuroscience.

[131]  B. M. Spruijt,et al.  Prenatal exposure to morphine affects juvenile play behavior and adult social behavior in rats , 1996, Pharmacology Biochemistry and Behavior.

[132]  H. Steiner,et al.  Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin , 1996, Nature.

[133]  A. Ornoy,et al.  The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted. , 1996, Child abuse & neglect.

[134]  B. Roques,et al.  Implication of endogenous opioid system in the learned helplessness model of depression , 1995, Pharmacology Biochemistry and Behavior.

[135]  R. Tao,et al.  Involvement of the dorsal raphe but not median raphe nucleus in morphine-induced increases in serotonin release in the rat forebrain , 1995, Neuroscience.

[136]  J. García-Sevilla,et al.  Increased density of μ-opioid receptors in the postmortem brain of suicide victims , 1995, Brain Research.

[137]  L. Vanderschuren,et al.  μ- and κ-opioid receptor-meiated opioid effects on social play in juvenile rats , 1995 .

[138]  C. Heyser,et al.  Chronic variable stress or chronic morphine facilitates immobility in a forced swim test: reversal by naloxone , 1994, Psychopharmacology.

[139]  B. Roques,et al.  Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat , 1993, Biological Psychiatry.

[140]  G. Gessa,et al.  Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanis , 1993, Brain Research.

[141]  M. M. de Cubas,et al.  Children of methadone-dependent women: developmental outcomes. , 1993, The American journal of orthopsychiatry.

[142]  Anat Biegon,et al.  Regionally selective increases in μ opioid receptor density in the brains of suicide victims , 1990, Brain Research.

[143]  S. Shelton,et al.  Defensive behaviors in infant rhesus monkeys: environmental cues and neurochemical regulation. , 1989, Science.

[144]  J. Bowlby.  Attachment and loss: retrospect and prospect. , 1982, The American journal of orthopsychiatry.

[145]  A. Kastin,et al.  Enkephalin and other peptides reduce passiveness , 1978, Pharmacology Biochemistry and Behavior.

[146]  A. Markou,et al.  Animal models and treatments for addiction and depression co-morbidity , 2009, Neurotoxicity Research.

[147]  J. Tassin.  Uncoupling between noradrenergic and serotonergic neurons as a molecular basis of stable changes in behavior induced by repeated drugs of abuse. , 2008, Biochemical pharmacology.

[148]  B. Lebowitz,et al.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. , 2006, The American journal of psychiatry.

[149]  A. Eisch,et al.  Opiates, psychostimulants, and adult hippocampal neurogenesis: Insights for addiction and stem cell biology , 2006, Hippocampus.

[150]  E. Jutkiewicz,et al.  Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats. , 2005, The Journal of pharmacology and experimental therapeutics.

[151]  A. Eschalier,et al.  Effects of morphine, naloxone and their interaction in the learned-helplessness paradigm in rats , 2005, Psychopharmacology.

[152]  E. Jutkiewicz,et al.  Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats. , 2004, The Journal of pharmacology and experimental therapeutics.

[153]  J. Kamei,et al.  Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. , 2004, Journal of pharmacological sciences.

[154]  A. Eschalier,et al.  Influence of naloxone on antidepressant drug effects in the forced swimming test in mice , 2004, Psychopharmacology.

[155]  S. Watson,et al.  The delta-opioid receptor agonist (+)BW373U86 regulates BDNF mRNA expression in rats. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[156]  P. Escribá,et al.  Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. , 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[157]  Jaak Panksepp,et al.  Neuroscience. Feeling the pain of social loss. , 2003, Science.

[158]  E. Jutkiewicz,et al.  Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. , 2002, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[159]  G. Koob,et al.  Increased ethanol self-administration in delta-opioid receptor knockout mice. , 2001, Alcoholism, clinical and experimental research.

[160]  A. Dierich,et al.  Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. , 2000, Nature genetics.

[161]  G. Ladd,et al.  Peer relationships and social competence during early and middle childhood. , 1999, Annual review of psychology.

[162]  L. Vanderschuren,et al.  Mu- and kappa-opioid receptor-mediated opioid effects on social play in juvenile rats. , 1995, European journal of pharmacology.